Young Tanzanians who have completed secondary school and degree holders are invited to apply for job opportunities as Fire ...
A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
We're learning more about the craving that fuels self-defeating habits—and how new discoveries can help us kick the habit. Addiction hijacks the brain’s neural pathways. Scientists are ...
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback